Riddle me this Batman?!
CL has the most Volume on any given Sunday, all while substantiated by the most Liquidity on the XRPL, yet XRPL protocols all use the same Automated Market Maker and we can’t get the perfect 50/50 display of the LP. I mean, we aren’t asking for you to fluff CL numbers. Just display the base stats we all are using on XRPL.

Just wanted to illustrate the devious behavior behind the Crypto scene behind these screens.

image

Riddle me this Batman?!
CL has the most Volume on any given Sunday, all while substantiated by the most Liquidity on the XRPL, yet XRPL protocols all use the same Automated Market Maker and we can’t get the perfect 50/50 display of the LP. I mean, we aren’t asking for you to fluff CL numbers. Just display the base stats we all are using on XRPL.

Just wanted to illustrate the devious behavior behind the Crypto scene behind these screens.

image

Riddle me this Batman?!
CL has the most Volume on any given Sunday, all while substantiated by the most Liquidity on the XRPL, yet XRPL protocols all use the same Automated Market Maker and we can’t get the perfect 50/50 display of the LP. I mean, we aren’t asking for you to fluff CL numbers. Just display the base stats we all are using on XRPL.

Just wanted to illustrate the devious behavior behind the Crypto scene behind these screens.

image
image
image
image

https://linktr.ee/cryptolandgame

https://www.aljazeera.com/news..../2024/9/5/dr-congo-e

rss
www.aljazeera.com

rss

Authorities aim to start vaccinations in October but face logistical challenges as doses need to be kept cold.

https://www.forbes.com/sites/r....oberthart/2024/09/04

image

https://www.forbes.com/sites/r....oberthart/2024/09/04

image

https://www.forbes.com/sites/r....oberthart/2024/09/04

image

https://www.forbes.com/sites/r....oberthart/2024/09/04

image

https://www.forbes.com/sites/r....oberthart/2024/09/04

Moderna’s mRNA Mpox Vaccine Beats Licensed Rivals In Early Test
www.forbes.com

Moderna’s mRNA Mpox Vaccine Beats Licensed Rivals In Early Test

The experimental mRNA shot, tested in macaques, generated a stronger immune response and dramatically reduced the number of mpox lesions in infected animals compared to Bavarian Nordic’s licensed vaccine, Jynneos.
image
image
image
image